Gorski J R, Muzi G, Weber L W, Pereira D W, Iatropoulos M J, Rozman K
Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, Kansas City 66103.
Toxicology. 1988 Dec 16;53(1):19-32. doi: 10.1016/0300-483x(88)90233-8.
The relationship between thymic atrophy and plasma corticosterone levels was examined in 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-treated, pair-fed and ad libitum-fed male Sprague-Dawley rats given a usually lethal (125 micrograms/kg) or non-lethal (25 micrograms/kg) dose of TCDD. At both dosages, corticosterone levels in TCDD-treated animals begun to rise as early as day 4 after treatment. At later time points corticosterone levels were 5-7 times higher in rats given the non-lethal dose, and 6-10 times higher in rats administered the lethal dose than the levels observed in ad libitum-fed controls. Corticosterone levels in control rats pair-fed to the lethal dose group (as a result of the severe reduction in feed intake) were similarly elevated as in TCDD-treated rats but this was not the case in pair-fed rats of the non-lethal TCDD dosage (due to an essentially unchanged feed intake). At both dosages, relative thymus weights of TCDD-treated rats started decreasing by day 4 and continued to decline for the most part of the study. Relative thymus weights of rats pair-fed to the non-lethal TCDD dosage were not different from ad libitum-fed rats. However, the decrease in relative thymus weights of rats pair-fed to the lethal TCDD dosage paralleled that of TCDD-treated rats with an apparent 8-day lag period. Morphologically, the thymus as well as the adrenal revealed differential changes in TCDD-treated rats from those observable in pair-fed rats. These results suggest that either TCDD exerts a direct effect on the thymus and the adrenals or it causes an additional stress (e.g., a metabolic stress) over and above the starvation stress, which may be responsible for the differential morphological changes in these glands.
在给予通常致死剂量(125微克/千克)或非致死剂量(25微克/千克)2,3,7,8-四氯二苯并对二恶英(TCDD)的雄性Sprague-Dawley大鼠中,研究了胸腺萎缩与血浆皮质酮水平之间的关系。这些大鼠分为TCDD处理组、配对喂食组和自由进食组。在两种剂量下,TCDD处理的动物血浆皮质酮水平在处理后第4天就开始升高。在随后的时间点,给予非致死剂量的大鼠皮质酮水平比自由进食对照组高5至7倍,给予致死剂量的大鼠皮质酮水平比自由进食对照组高6至10倍。与致死剂量组配对喂食的对照大鼠(由于采食量严重减少)的皮质酮水平与TCDD处理的大鼠相似升高,但非致死剂量TCDD的配对喂食大鼠并非如此(由于采食量基本未变)。在两种剂量下,TCDD处理的大鼠相对胸腺重量在第4天开始下降,并在研究的大部分时间内持续下降。与非致死剂量TCDD配对喂食的大鼠相对胸腺重量与自由进食大鼠无差异。然而,与致死剂量TCDD配对喂食的大鼠相对胸腺重量的下降与TCDD处理的大鼠平行,但有明显的8天延迟期。形态学上,TCDD处理的大鼠胸腺以及肾上腺与配对喂食大鼠相比有不同变化。这些结果表明,要么TCDD对胸腺和肾上腺有直接作用,要么它除了饥饿应激之外还引起额外的应激(例如代谢应激),这可能是这些腺体形态学差异变化的原因。